SCTCi043-A-1

iPS23-00086 clE2, fIPS_DM1Rescue_P1 clE2

The cell line is not validated yet.

General

Cell Line

hPSCreg name SCTCi043-A-1
Cite as:
SCTCi043-A-1
Alternative name(s)
iPS23-00086 clE2, fIPS_DM1Rescue_P1 clE2
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines No similar lines found.
Last update 15th December 2025
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Radboudumc - Department of Human Genetics (RMCGEN)

External Databases

BioSamples SAMEA119974286

General Information

* Is the cell line readily obtainable for third parties?
No
Subclone of

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • DM1
  • DMPK myotonic dystrophy
  • MD1
  • Steinert disease
  • Steinert myotonic dystrophy syndrome
  • Steinert syndrome
  • dystrophia myotonica
  • myotonic dystrophy caused by mutation in DMPK
  • myotonic dystrophy of Steinert
  • myotonic dystrophy type 1
  • Steinert myotonic dystrophy
  • Steinert's disease
  • dystrophia myotonica 1
  • dystrophia myotonica type 1
  • myotonic dystrophy 1
  • Myotonic Dystrophy
show more synonyms

External Databases (Donor)

BioSamples SAMEA119974255

Ethics

Also have a look at the ethics information for the parental line SCTCi043-A .
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line SCTCi043-A.

Reprogramming method

Vector type Integrating
Vector Virus (Lentivirus)
Genes
Is the used vector excisable?
No
Absence of reprogramming vector(s)?
No
Reprogramming vectors silenced?
Yes
Methods used
RT-PCR
Files and images showing reprogramming vector expressed or silenced

Vector free reprogramming

Other

Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 20 %
CO2 Concentration 5 %
Medium Essential 8™ Flex

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
SOX2
Yes
NANOG
Yes
SSEA-4
Yes
TRA 1-81
Yes
DNMT3B
Yes
LIN28A
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
FOXA2
Yes
SOX17
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
HAND1
Yes
TBXT (BRACHYURY)
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
PAX6
Yes
NCAM1
Yes

Microbiology / Virus Screening

Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46,XY
Passage number: 12
Karyotyping method: CNV-WES

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
Synonyms
  • DM1
  • DMPK myotonic dystrophy
  • MD1
  • Steinert disease
  • Steinert myotonic dystrophy syndrome
  • Steinert syndrome
  • dystrophia myotonica
  • myotonic dystrophy caused by mutation in DMPK
  • myotonic dystrophy of Steinert
  • myotonic dystrophy type 1
  • Steinert myotonic dystrophy
  • Steinert's disease
  • dystrophia myotonica 1
  • dystrophia myotonica type 1
  • myotonic dystrophy 1
  • Myotonic Dystrophy
show more synonyms
Genetic modifications
Isogenic modification
Heterozygous
Non-homologous endjoining by dual CRISPR, excision of mutated repeat.
Changed